Diagnostic Microbiology & Infectious Disease
Volume 45, Issue 1 , Pages 1-11 , January 2003

Moellerella wisconsensis: identification, natural antibiotic susceptibility and its dependency on the medium applied

  • Ingo Stock

      Affiliations

    • Institute of Medical Microbiology and Immunology, Pharmaceutical Microbiology, University of Bonn, Bonn, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49-228-732114; fax: +49-228-735267.
    • ,
  • Enevold Falsen

      Affiliations

    • Department of Clinical Bacteriology, University of Göteborg, Göteborg, Sweden
    • ,
  • Bernd Wiedemann

      Affiliations

    • Institute of Medical Microbiology and Immunology, Pharmaceutical Microbiology, University of Bonn, Bonn, Germany

Received 19 February 2002 ,Accepted 21 August 2002.

References 

  1. Aldová, E. (1992). Informations on strains sent to the Bacteria Culture Collection of the University of Göteborg, Sweden. CCUG data base (http://www.ccug.gu.se/search/search_cfs.cfm) on Moellerella
  2. Amsterdam D. Susceptibility testing of antimicrobials in liquid media. In:  Lorian V editors. Antibiotics in laboratory medicine. 4th ed.. Baltimore: Williams and Wilkins; 1996;p. 52–111
  3. Bangert RL, Ward AC, Stauber EH, Cho BR, Widders PR. A survey of the aerobic bacteria in the feces of captive raptors. Avian Dis. 1988;32:53–62
  4. Barry AL, Fuchs PC. In vitro susceptibility testing procedures for fosfomycin tromethamine. Antimicrob Agents Chemother. 1991;35:1235–1238
  5. Blekher L, Siegman-Igra Y, Schwartz D, Berger SA, Carmeli Y. Clinical significance and antibiotic resistance patterns of Leminorella spp., an emerging nosocomial pathogen. J Clin Microbiol. 2000;38:3036–3038
  6. Brenner D. J. (1992). Additional genera of Enterobacteriaceae. In: The Prokaryotes. A handbook on the biology of bacteria: ecophysiology, isolation, identification, applications, Vol. 1, pp. 2922–37. Springer, NY
  7. Cabadajova D, Kudrna L. Moellerella wisconsensis—the first isolation and identification of a new genus and species of the family Enterobacteriaceae in Czechoslovakia. Cesk Epidemiol Mikrobiol Imunol (Prague). 1988;37:45–48 (In Czech)
  8. Clark RB, Lister PD, Janda JM. In vitro susceptibilities of Edwardsiella tarda to 22 antibiotics and antibiotic-β-lactamase-inhibitor agents. Diagn Microbiol Infect Dis. 1991;14:173–175
  9. Comité de l’Antibiogramme de la Société Française de Microbiologie Communiqué. (1998). Statement. Pathol Biol, 46, I–XVI
  10. Curtis NAC, Brown C, Boxall M, Boulton MG. Inhibition of Escherichia coli K-12 by β-lactam antibiotics with poor antibacterial activity (interaction of permeability and intrinsic activity against penicillin-binding proteins). Antimicrob Agents Chemother. 1979;15:332–336
  11. Deutsches Institut für Normung e. V. (1998). DIN document 58940-4, Table 1. Susceptibility testing of pathogens to antimicrobial agents, part 4: Evaluation classes of the minimum inhibitory concentration, Supplement 1: MIC breakpoints of antibacterial agents. Deutsches Institut für Normung e. V., Berlin, Germany
  12. European Committee on Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) . Linezolid breakpoints. Clin Microbiol Infect. 2001;7:283–284
  13. Farmer JJ. Enterobacteriaceae: introduction and identification. In:  Murray P,  Baron E,  Pfaller M,  Tenover F,  Yolken R editor. Manual of Clinical Microbiology. New York: American Society of Microbiology; 1995;p. 438–449
  14. Goldstein EJ, Lewis RP, Martin WJ, Edelstein PH. Infections caused by Klebsiella ozaenae (a changing disease spectrum). J Clin Microbiol. 1978;8:413–418
  15. Hickman-Brenner FW, Huntley-Carter GP, Saitoh Y, Steigerwalt AG, Farmer JJ, Brenner DJ. Moellerella wisconsensis, a new genus and species of Enterobacteriaceae found in human stool specimens. J Clin Microbiol. 1984;19:460–463
  16. Kresken M, Hafner D  the study group ‘Resistance’ of the Paul Ehrlich Society for Chemotherapie e.V. . Resistenzsituation bei klinisch wichtigen Infektionserregern gegenüber Chemotherapeutika in Mitteleuropa. Chemother J. 2000;9:51–86

    (In German)

  17. Livermore DM. β-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev. 1995;8:557–584
  18. Livermore DM. β-Lactams (mode of action and mechanisms of bacterial resistance). In:  Lorain V editors. Antibiotics in laboratory medicine. Baltimore: Williams & Wilkins; 1996;p. 502–578
  19. Marshall AR, Al-Jumaili IJ, Bint AJ. The isolation of Moellerella wisconsensis from stool samples in the U.K. J Infect. 1986;12:31–33
  20. National Committee for Clinical Laboratory Standards. (2000a). NCCLS document M7-A5, Table 2A. Minimum inhibitory concentration (MIC) interpretive standards (μg/ml) for Enterobacteriaceae. National Committee for Clinical Laboratory Standards, Villanova, Pa
  21. National Committee for Clinical Laboratory Standards. (2000b). NCCLS document M7-A5, Table 2B. Minimum inhibitory concentration (MIC) interpretive standards (μg/ml) for Pseudomonas aeruginosa and other Non-Enterobacteriaceae. National Committee for Clinical Laboratory Standards, Villanova, Pa
  22. National Committee for Clinical Laboratory Standards. (2000c). NCCLS document M7-A5, Table 2C. Minimum inhibitory concentration (MIC) interpretive standards (μg/ml) for Staphylococcus spp. National Committee for Clinical Laboratory Standards, Villanova, Pa
  23. National Committee for Clinical Laboratory Standards. (2000d). NCCLS document M7-A5, Table 2F. Minimum inhibitory concentration (MIC) interpretive standards (μg/ml) for Neisseria gonorrhoe. National Committee for Clinical Laboratory Standards, Villanova, Pa
  24. Nikaido H. Outer membrane. In:  Neidhardt FC editors. Escherichia coli and Salmonella typhimurium, cellular and molecular biology. Washington, DC: American Society of Microbiology; 1996;p. 29–47
  25. Normark S, Grundstrom T, Bergstrom S. Susceptibility to penicillins and cephalosporins in β-lactamase producing strains of Escherichia coli and relative amount of β-lactamase produced by these strains. Scand J Infect Dis. 1980;25:23–29
  26. Ohanessian JH, Fourcade N, Priolet B, Richard C, Bashour G, Dugelay M. A propos d′une infection vésiculaire par Moellerella wisconsensis. Méd Malad Infect. 1987;6:414–416 (In French)
  27. O′Hara K. Two different types of fosfomycin resistance in clinical isolates of Klebsiella pneumoniae. FEMS Microbiol Lett. 1993;114:9–16
  28. Olsson-Liljequist B, Larson P, Walder M, Miörner H. Antimicrobial susceptibility testing in Sweden. Part 3 (Methology for susceptibility testing). Scand J Infect Dis. 1997;105(Supplement):13–23
  29. Patel SS, Balfour JA, Bryson HM. Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections. Drugs. 1997;53:637–656
  30. Ramia S, Neter E, Brenner DJ. Production of enterobacterial common antigen as an aid to classification of newly identified species of the families Enterobacteriaceae and Vibrionaceae. J Clin Microbiol. 1982;32:395–398
  31. Reger PJ, Mockler DF, Miller MA. Comparison of antimicrobial susceptibility, β-lactamase production, plasmid analysis and serum bactericidal activity in Edwardsiella tarda, E. ictaluri and E. hoshinae. J Med Microbiol. 1993;39:273–281
  32. Richard C. Nouvelles Enterobacteriaceae rencontrées enbactériologie médicale (Moellerella wisconsensis, Koserella trabulsii, Leclercia adecarboxylata, Escherichia fergusonii, Enterobacter asburiae, Rahnella aquatilis). Annals Biol Clin. 1989;47:231–236 (In French)
  33. Soussy, C. J., Goldstein, F., Bryskier, A., Drugeon, H., Andrews, J., Baquero, F., Cars, O., Felmingham, D., Olsson-Liljequist, B., Rodloff, A., Schito, G. C., Wiedemann, B., & Wise, R. (2000). Telithromycin: assessment of susceptibility testing. International Congress of Antimicrobial Agents and Chemotherapy, Toronto 2000 (Poster presentation)
  34. Stock, I. (1999). Die natürliche Antibiotika-Empfindlichkeit der Enterobacteriaceae, Dissertation, Bonn. (In German)
  35. Stock I, Grüger T, Wiedemann B. Natural antibiotic susceptibility of strains of the Enterobacter cloacae complex. Int J Antimicrob Agents. 2001;18:537–545
  36. Stock I, Wiedemann B. Natürlich Antibiotika-Empfindlichkeit von Proteus-Spezies im Proteus-vulgaris-Komplex. Chemother J. 1997;6:76–84 (In German)
  37. Stock I, Wiedemann B. Identification and natural antibiotic susceptibility of Morganella morganii. Diagn Microbiol Infect Dis. 1998;30:53–65
  38. Stock I, Wiedemann B. Natural antibiotic susceptibility of Providencia stuartii, P. rettgeri, P. alcalifaciens and P. rustigianii strains. J Med Microbiol. 1998;47:629–642
  39. Stock I, Wiedemann B. An in-vitro study of the antimicrobial susceptibilities of Yersinia enterocolitica and the definition of a database. J Antimicrob Chemother. 1999;43:37–45
  40. Stock I, Wiedemann B. Natural antibiotic susceptibility of Escherichia coli, Shigella, E. vulneris, and E. hermannii strains. Diagn Microbiol Infect Dis. 1999;33:187–199
  41. Stock I, Wiedemann B. Natural β-lactam susceptibility and mechanisms of β-lactam resistance in Yersinia enterocolitica. Rev Med Microbiol. 2000;11:197–210
  42. Stock I, Wiedemann B. Natural antibiotic susceptibilities of Edwardsiella tarda, E. ictaluri, and E. hoashinae. Antimicrob Agents Chemother. 2001;45:2245–2255
  43. Stone, G., Nilius, A., Hensey, D., Almer, L., Beyer, J., & Flamm, R. (2000). Development of tentative interpretive criteria for ABT-773, a novel ketolide antibacterial agent. International Congress of Antimicrobial Agents and Chemotherapy, Toronto 2000 (Poster presentation)
  44. Tang LM, Chen ST. Klebsiella ozaenae meningitis (report of two cases and review of the literature). Infection. 1994;22:58–61
  45. Tang LM, Chen ST, Hsu WC, Chen CM. Klebsiella meningitis in Taiwan (an overview). Epidemiol Infect. 1997;119:135–142
  46. Troxler R, von Graevenitz A, Funke G, Wiedemann B, Stock I. Natural antibiotic susceptibility of Listeria species (L. grayi, L. innocua, L. ivanovii, L. monocytogenes, L. seeligeri and L. welshimeri strains). Clin Microbiol Infect. 2000;6:525–535
  47. Wallet F, Fruchart A, Bouvet PJM, Courcol RJ. Isolation of Moellerella wisconsensis from bronchial aspirate. Eur J Clin Microbiol Infect Dis. 1994;13:182–183
  48. Wittke JW, Aleksic S, Wuthe HH. Isolation of Moellerella wisconsensis from an infected human gall bladder. Eur J Clin Microbiol. 1985;4:351–352

PII: S0732-8893(02)00483-2

doi: 10.1016/S0732-8893(02)00483-2

Diagnostic Microbiology & Infectious Disease
Volume 45, Issue 1 , Pages 1-11 , January 2003

Article Tools